Targeting Bacterial Central Metabolism for Drug Development
- 1 November 2014
- journal article
- review article
- Published by Elsevier in Chemistry & Biology
- Vol. 21 (11) , 1423-1432
Abstract
No abstract availableKeywords
This publication has 115 references indexed in Scilit:
- 13C-Flux Spectral Analysis of Host-Pathogen Metabolism Reveals a Mixed Diet for Intracellular Mycobacterium tuberculosisChemistry & Biology, 2013
- A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicating Mycobacterium tuberculosisACS Chemical Biology, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- Copper in Microbial Pathogenesis: Meddling with the MetalCell Host & Microbe, 2012
- Metabolomics implicates altered sphingolipids in chronic pain of neuropathic originNature Chemical Biology, 2012
- Bisubstrate Adenylation Inhibitors of Biotin Protein Ligase from Mycobacterium tuberculosisChemistry & Biology, 2011
- Antifolate-Induced Depletion of Intracellular Glycine and Purines Inhibits Thymineless Death in E. coliACS Chemical Biology, 2010
- Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coliNature Chemical Biology, 2009
- Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapyNature Biotechnology, 2008
- ROS stress in cancer cells and therapeutic implicationsDrug Resistance Updates, 2004